ClinicalTrials.Veeva

Menu

Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Medical College of Wisconsin logo

Medical College of Wisconsin

Status

Terminated

Conditions

Idiopathic Pulmonary Fibrosis

Treatments

Other: Multi-Disciplinary Patient Centered Rehab and Education

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, with 90% of patients reporting dyspnea at the time of diagnosis and this is strongly correlated with quality of life and mortality. As IPF progress, breathlessness worsens, physical functional capacity declines, and health-related quality of life deteriorates. Pulmonary rehabilitation (PR) can improve well-being in patients with other chronic lung disease, but little is known regarding PR in IPF.

Full description

The hypothesis is that the provision of a comprehensive pulmonary rehabilitation program to patients with IPF will significantly improve participant health related quality of life. The objective is to develop a comprehensive, multi-disciplinary 12-week PR program with disease specific educational components for IPF patients. The specific aims of the proposal is to evaluate the effect of the comprehensive PR program on 1) improvements in quality of life using the Medical Outcomes Study 36-Item Short Form 36 (SF-36), a quality of life instrument and 2) improvements in patient self-reported dyspnea scores using the chronic respiratory questionnaire. The investigator intends to evaluate sustained benefits of the PR intervention, changes in depression, anxiety, stress and functional physical capacity.

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of IPF confirmed by lung biopsy or by characteristic pattern on high resolution computed tomogram (HRCT)
  • No identifiable cause of lung fibrosis
  • PR not received in the past year
  • Ability to walk

Exclusion criteria

  • History of unstable angina
  • Deterioration cardiac or neurological disease
  • Pregnancy or lactation
  • Degenerative arthritis or other limitation to mobility
  • PR in the past 12 months

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

Single Arm
Other group
Description:
This project is being withdrawn. No revisions to ARM is available. Patients will undergo consultation and education by members of a pre-determined multi-disciplinary team that aims to bring a predetermined set of services to the patient in a coordinated and scheduled manner in order to facilitate a comprehensive and through approach to the patient's entire well being
Treatment:
Other: Multi-Disciplinary Patient Centered Rehab and Education

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems